BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

OPMEDIC GROUP Announces the Acquisition of the Operations of Northern Reproductive Therapies Inc.


8/1/2012 12:26:29 PM

MONTREAL, Aug. 1, 2012 /CNW Telbec/ - OPMEDIC GROUP INC. ("OPMEDIC GROUP") (TSX: OMG) is pleased to announce that it has completed the acquisition effective August 1, 2012, of all of the issued and outstanding shares of Northern Reproductive Therapies Inc. ("NRT") (the "Acquisition").

NRT operates a small fertility clinic north of Toronto in the Town of Newmarket, about 25 km north of the City of Toronto. The clinic offers fertility treatments other than egg retrievals and embryo transfers.

The Acquisition will allow OPMEDIC GROUP to expand its presence in Ontario in the north and central York Region area and will also allow the creation of synergy between NRT's clinic and the full services of PROCREA Fertility Centre situated in Vaughan (Ontario) through an increased volume of patient referrals.

"The Acquisition of Northern Reproductive Therapies is another step towards OPMEDIC GROUP's strategic plan and growth strategy to expand our fertility services activities outside Quebec. With our strong balance sheet, we will continue to pursue targeted acquisitions to enhance the corporation's position as a leader in Canada in fertility services", said Dr. Pierre St-Michel, president and CEO of OPMEDIC GROUP.

About OPMEDIC GROUP

OPMEDIC GROUP is a corporation incorporated under the laws of the Province of Quebec which provides healthcare-related services including surgical and endoscopic facilities and services to patients and surgeons (with its OPMEDIC division), fertility treatments, medical imaging, laboratory services and diagnostic procedures (with its PROCREA Cliniques division and one of its joint ventures) and sperm banking services (with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common Shares trade on the Toronto Stock Exchange under the symbol "OMG".

This news release does not constitute an offer to sell or to solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering would be unlawful. This news release contains certain forward-looking statements that reflect the current views and/or expectations of OPMEDIC GROUP with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.

The content of this press release has not been approved by nor submitted to the TSX which assumes no liability therefore.

SOURCE: OPMEDIC GROUP INC.

For further information:

Paulo BOUÇA

Chief Operating Officer and Vice-President, Business Development

(514) 345-8535, x 2254

pbouca@groupeopmedic.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES